Horizon HQ Slips 300 Testing 1124 Support 20260515 BeyondSpring BYSI Q1 2026 Results Meet Expectations Revenue NA Stock Market Today Dow Futures Steady as Oil Falls on Iran Developments Nvidia Walmart Earnings in Focus Cintas Roar Logistics and Lumsden McCormick Forge Industry Alliance Reports The Business Journals Barclays Reports 18 Profit Increase Raises FullYear Income Guidance Manchesters Defining Spirit of Collectivism and Entrepreneurialism May Influence UK National Policy Pokmon Card Market Booms on Nostalgia and Speculation Inside the MultiMillion Dollar Trading Frenzy SK Hynix Surpasses 1 Trillion Market Cap as AI Demand Drives Chip Stock Surge Feds Waller Joins Policymakers Signaling Potential Rate Hike as Next Move Deere Beats Fiscal Q2 Estimates on Tariff Refund Lifts Outlook as Construction Segment Offsets Farm Weakness Vivani Medical VANI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction Pentair Q1 2026 Earnings EPS Beats Estimates by 329 Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline Robert Half Q1 2026 Earnings EPS Beat of 878 Drives Positive Investor Sentiment GPK Q1 2026 Earnings EPS Surpasses Expectations on 5598 Surprise PDEX Q1 2026 Earnings EPS Surging 8975 Above Estimates Frontdoor Inc FTDR Edges Higher as Key Support Holds Steady GigCapital7 Unit GIGGU Holds Steady at 994 as Market Digests SPAC Dynamics JBS NV JBS Declines as Market Pressures Mount Key Levels to Watch DarkIris Inc DKI Declines 213 as Stock Approaches Key Support Zone Ultragenyx RARE Edges Lower as Resistance Holds Support Levels Eyed Kevin Hassett Hails Record Consumer Spending as Delinquencies Rise and Farm Bankruptcies Surge 46 ENLT Q1 2026 Earnings Positive EPS Surprise Drives Modest Stock Gain Currenc Group Inc CURR Consolidates Near Support as Trading Activity Remains Subdued Theriva Biologics TOVX Q1 2026 Earnings Slight EPS Beat Boosts Sentiment for ClinicalStage Biotech NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline TAC Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Momentum CAAP Q1 2026 Earnings EPS Misses Consensus by 75 as Operating Costs Weigh BIP Q1 2026 Earnings Significant EPS Miss Amidst Operational Headwinds QH Q4 2021 Earnings Massive EPS Miss Highlights Operational Challenges FITBI Q1 2026 Earnings Strong EPS Beat Highlights Resilient Core Operations